To include your compound in the COVID-19 Resource Center, submit it here.

Human Genome starts repifermin Phase IIb

HGSI began double-blind, placebo-controlled U.S. Phase IIb

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE